Governor of the French Central Bank, François Villeroy de Galhau: The Middle East shock impacts all economies, and rising interest rates affect both strong and weak fiscal states alike
智通财经2026/10/08 07:36(1) Banque de France Governor François Villeroy de Galhau stated that the Middle East crisis has triggered geopolitical shocks impacting all economies, including those with relatively strong public finances. (2) As a member of the European Central Bank’s Governing Council, he did not directly mention France’s current difficulties when discussing inflation’s impact on global bond yields. (3) Villeroy de Galhau said, “We observe a strong correlation between oil prices, US long-term interest rates, and European interest rates. This rise in rates affects all countries, regardless of their fiscal health. In fact, some countries with very strong public finances are equally affected, just like those in weaker fiscal positions.” (4) France is currently under close investor scrutiny as it strives to pass a budget and narrow its large fiscal deficit, with related tensions evoking memories of the eurozone debt crisis. (5) Earlier on Thursday, French Finance Minister Bruno Le Maire insisted that there is no difficulty selling French government bonds. (6) Villeroy de Galhau also pointed out that consumer price increases driven by oil and gas price shocks have not significantly spread to other sectors.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AstraZeneca (AZN.US) and Daiichi Sankyo (DSNKY.US) TROP2 ADC receives approval for new indication in China
According to information from Zhihu Finance APP, AstraZeneca (AZN.US) and Daiichi Sankyo (DSNKY.US) have announced that Datroway® (generic name: datopotamab deruxtecan for injection) has been approved by the National Medical Products Administration (NMPA) of China for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (TNBC) who are not suitable for PD-1/PD-L1 inhibitor therapies. Datopotamab deruxtecan is an antibody-drug conjugate (ADC) targeting TROP2, developed with proprietary technology by Daiichi Sankyo, and jointly developed and commercialized by AstraZeneca and Daiichi Sankyo.
Abu Dhabi National Oil Company invites bids for crude oil cargo shipments
Trader: Abu Dhabi National Oil Company issued a tender this week to sell crude oil for December loading or January delivery.
The Central Bank of Turkey conducts a 6-ton gold-for-lira weekly sell swap auction.
The Central Bank of Turkey conducted a one-week gold-for-lira sell swap auction using traditional methods, with a scale of 6 tons.
European Court of Auditors: EU debt continues to rise and may reach 1 trillion euros by 2027
On October 8 local time, the European Court of Auditors (ECA) released its 2025 annual report, expressing concerns over the continuous growth of EU debt. According to the report, by the end of 2025, the EU's debt had reached approximately 740 billion euros. The report also warns that this figure may further rise to 1 trillion euros by 2027. The ECA pointed out that the increase in EU debt is mainly related to aid for Ukraine, rising interest rates, defense spending, and the EU recovery fund. (CCTV)
Crypto prices
More
